A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly ...
We demonstrated for the first time that Hv1 is present and functional on endosomes. Additionally, Hv1 controlled actin cytoskeleton function via a protein called CapZ. The actin cytoskeleton was also ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A cell-penetrating nanobody restores function in cystic fibrosis—and points to a new class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results